FDA Approves Exelon Patch for Severe Alzheimer’s – Medscape

June 28, 2013 by  
Filed under Alzheimers News

Sponsored By
FDA Approves Exelon Patch for Severe Alzheimer's
Medscape
The approval in severe AD was based on the ACTION (ACTivities of Daily Living and CognitION in Patients with Severe Dementia of the Alzheimer's Type) study, a randomized, double-blind trial comparing the 13.3 mg/24h dose patch with the higher 4.6 
FDA Approves Novartis Exelon Patch For Expanded Indication Of Severe RTT News
FDA approves patch to treat all stages of Alzheimer'sHealio
Exelon Patch Approved for All Stages of Alzheimer'sMonthly Prescribing Reference

all 6 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*